$NTLA 4/A SEC Filings

Filed On	Filing
14 Apr 2022	Form 4/A: Keresty Georgia, Director Received 1,569 shares as a grant or award · Granted 2,534 Stock Option (right to buy)
04 Mar 2022	Form 4/A: Basta James, EVP, General Counsel Granted 14,109 Stock Option (right to buy)
04 Mar 2022	Form 4/A: Goddard Glenn, EVP, Chief Financial Officer Granted 18,600 Stock Option (right to buy)
04 Mar 2022	Form 4/A: Lebwohl David, EVP, Chief Medical Officer Granted 20,203 Stock Option (right to buy)
04 Mar 2022	Form 4/A: Sepp-Lorenzino Laura, EVP, Chief Scientific Officer Granted 20,203 Stock Option (right to buy)
20 Dec 2018	Form 4/A: Goddard Glenn, See Remarks Granted 90,000 Stock Option (Right to Buy)

Comments